Compare BWMX & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BWMX | DNA |
|---|---|---|
| Founded | 1995 | 2008 |
| Country | Mexico | United States |
| Employees | N/A | 485 |
| Industry | Catalog/Specialty Distribution | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 644.3M | 599.0M |
| IPO Year | 2019 | N/A |
| Metric | BWMX | DNA |
|---|---|---|
| Price | $18.58 | $8.30 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 2 |
| Target Price | ★ $27.83 | $8.50 |
| AVG Volume (30 Days) | 46.9K | ★ 1.2M |
| Earning Date | 04-23-2026 | 05-07-2026 |
| Dividend Yield | ★ 9.11% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $18.17 | N/A |
| Revenue Next Year | $25.68 | N/A |
| P/E Ratio | $12.54 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.15 | $5.37 |
| 52 Week High | $19.79 | $17.58 |
| Indicator | BWMX | DNA |
|---|---|---|
| Relative Strength Index (RSI) | 55.37 | 37.96 |
| Support Level | $17.37 | $7.59 |
| Resistance Level | $19.40 | $10.27 |
| Average True Range (ATR) | 0.50 | 0.71 |
| MACD | 0.02 | -0.22 |
| Stochastic Oscillator | 58.39 | 2.93 |
Betterware de Mexico SAPI de CV is a company in the consumer product goods industry focused on home organization and beauty and personal care products, commercialized through person-to-person selling. The Group operates through two segments: Home organization under the Betterware brand, including kitchen and food preservation, home solutions, bathroom, laundry & cleaning, tech and mobility, bedroom and wellness. Products are sold through catalogues and distributed through distributors and associates. The Beauty and personal care (B&PC) segment under the JAFRA brand, which generates maximum revenue, includes fragrance, color, skin care and toiletries, distributed through leaders and consultants. The Group operates in Mexico, which generates maximum revenue, the United States and Latam.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.